关注
Karin M Durant
Karin M Durant
Michigan Medicine, University of Michigan
在 umich.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases
B Bazzell, D Wagner, KM Durant, B Callahan
American Journal of Health-System Pharmacy 77 (21), 1763-1770, 2020
62020
Impact of an electronic health record alert on inappropriate prescribing of high-risk medications to patients with concurrent “do not give” orders
K Smith, KM Durant, C Zimmerman
American Journal of Health-System Pharmacy 79 (14), 1198-1204, 2022
32022
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura
JH Reid, KM Durant, SL Chen, AJ Perissinotti, R King, R Khoriaty, ...
Journal of Oncology Pharmacy Practice 26 (7), 1695-1702, 2020
32020
A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics
KM Durant, A Whitesell, KD Dasse
American Journal of Health-System Pharmacy, zxae031, 2024
2024
系统目前无法执行此操作，请稍后再试。
文章 1–4